肺纤维化的治疗现状及展望

被引:3
作者
张丽
邹立群
机构
[1] 四川大学华西医院肿瘤中心
关键词
肺纤维化; 肿瘤; 治疗;
D O I
暂无
中图分类号
R563.9 [其他];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:100 / 103
页数:4
相关论文
共 47 条
[11]  
The diagnosis,assess-ment and treatment of diffuse parenchymal lung disease in adults. Gushley MJ,Davison A G,Bois du RM. Thorax . 1999
[12]  
Effects of1-year treatment with cyclophosphamide on outcomes at2years in sclero-derma lung disease. Tashkin DP,Elashoff R,Clements PJ,et al. American Journal of Respiratory and Critical Care Medicine . 2007
[13]  
NITRIC OXIDE[P]. 英国专利:GB8516333D0,1985-07-31
[14]  
Idiopathic pulmonary fibrosis:is it really a forme fruste of limited autoimmune disease related to endothelial injury and anti-endothelial cell antibodies-Ahypothesis. Magro CM,Waldman J,Knight DA,et al. Huma Immunology . 2006
[15]  
Antigen receptor signal-ling:a distinctive role for the pllodelta isoform of PI3K. Okkenhaug K,Ali K,Vanhaesebroeck B. Trends in Immunology . 2007
[16]  
Anti-inflammatory activity of the new mould meta-bolite11-desacetoxy-wortmannin and of some of its derivatives. Wiesinger D,Gubler HU,Haefliger W,et al. Experientia . 1974
[17]  
PI3Kγinhibition:towards an‘aspirin of the21stcen-tury’-. Ruckle T. Nature Reviews Drug Discovery . 2006
[18]  
Prognosis of idiopathic pulmonary fibrosis in-patients with mucous hypersecretion. Hiwatari,N.,Shimura,S.,Sasaki,T.,Aikawa,T.,Ando,Y.,Ishihara,H.,Sekizawa,K.,Sasaki,H.,Takishima,T. The American Review of Respiratory Disease . 1991
[19]  
Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Gharaee-Kermani,M.,Phan,S. H. Current Pharmaceutical Design . 2005
[20]  
TGF-β1,radiation-induced pulmonary injury and lung cancer. Vujaskovic Z,Groen HJM. International Journal of Radiation Oncology Biology Physics . 2000